🔗 Share this article

Treasury head Rachel Reeves has announced she is planning "targeted measures to tackle cost of living pressures" in the upcoming Budget.

In comments to media outlets, she noted that curbing price rises is a collective responsibility of both the administration and the central bank.

The United Kingdom's price growth is projected to be the most elevated among the G7 advanced economies this calendar year and next.

Possible Utility Bill Measures

Sources suggest the government could intervene to bring down utility costs, such as by cutting the present 5% level of value-added tax applied on energy.

Another option is to cut some of the regulatory levies presently added to bills.

Fiscal Limitations and Expert Predictions

The government will receive the latest report from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will clarify how much scope there is for such actions.

The consensus from most experts is that the Chancellor will have to announce tax rises or expenditure reductions in order to adhere to her self-imposed borrowing rules.

Earlier on the same day, calculations indicated there was a £22 billion deficit for the chancellor to resolve, which is at the more modest range of expectations.

"There's a joint task between the central bank and the administration to bear down further on some of the drivers of price increases," the Chancellor stated to the BBC in Washington, at the annual meetings of the International Monetary Fund and global financial institution.

Revenue Commitments and International Concerns

While much of the focus has been on probable tax rises, the chancellor said the most recent data from the fiscal watchdog had not changed her commitment to campaign commitments not to raise tax levels on income tax, VAT or social security contributions.

She blamed an "unpredictable world" with rising geopolitical and trade concerns for the Budget revenue measures, likely to be directed on those "most able to pay."

Global Economic Disputes

Addressing apprehensions about the UK's economic relations with the Asian nation she said: "Our national security invariably are paramount."

Recent announcement by Chinese authorities to strengthen trade restrictions on rare earths and other materials that are essential for advanced tech production led American leader the US President to propose an additional 100% import tax on goods from the Asian country, raising the possibility of an full-scale commercial conflict between the two largest economies.

The US Treasury Secretary labeled China's action "commercial pressure" and "a international production control attempt."

Asked about accepting the American proposal to join its battle with the Asian nation, Reeves said she was "deeply worried" by Chinese measures and encouraged the Beijing authorities "not to put up barriers and restrict access."

She said the decision was "harmful for the international commerce and causes additional headwinds."

"It is my opinion there are sectors where we should confront Chinese policies, but there are also important opportunities to export to China's economy, including banking sector and other sectors of the economic system. We've got to maintain that equilibrium right."

The chancellor also confirmed she was working with G7 counterparts "regarding our own critical minerals approach, so that we are more independent."

Health Service Drug Pricing and Funding

The Chancellor also admitted that the cost the National Health Service pays for medicines could increase as a consequence of current talks with the US government and its drugs companies, in exchange for reduced taxes and capital.

A number of the biggest global pharmaceutical manufacturers have said lately that they are either halting or scrapping investments in the UK, with several blaming the insufficient payments they are getting.

Recently, the government science advisor said the price the health service spends on medicines would need to increase to halt companies and pharmaceutical investment leaving the UK.

Reeves informed the BBC: "It has been observed as a result of the payment system, that medical research, innovative medicines have not been available in the UK in the manner that they are in other continental states."

"Our aim is to make sure that individuals receiving treatment from the National Health Service are can receive the top essential drugs in the world. And so we are reviewing these issues, and... aiming to obtain more investment into Britain."